Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00602303
NCT00602303CompletedNot Applicable

A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalency Study of 20 mg Torsemide Tablets Under Fasting Conditions

Roxane Laboratories1 site in 1 country28 target enrollmentStarted: September 1, 2003Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
28
Locations
1
Primary Endpoint
Bioequivalence
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The objective of this study was the bioequivalence of a Roxane Laboratories' Torsemide Tablets, 20 mg, to Demadex® Tablets, 20 mg (Roche) under fasting conditions using a single-dose, 2-treatment, 2-period, crossover design.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening.

Exclusion Criteria

  • •Positive test for HIV, Hepatitis B, or Hepatitis C.
  • •Treatment with known enzyme altering drugs.
  • •History of allergic or adverse response to Torsemide or any comparable or similar product.

Outcomes

Primary Outcomes

Bioequivalence

Time Frame: Baseline, Two period, Seven day washout

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Bioequivalency Study of Torsemide Tablets Under Fed ConditionsEdema
NCT00602615Roxane Laboratories28
Completed
Not Applicable
Bioequivalency Study of Meloxicam Tablets Under Fasting ConditionsInflammation
NCT00618163Roxane Laboratories47
Completed
Not Applicable
Bioequivalency Study of Meloxicam Tablets Under Fed ConditionsInflammation
NCT00601887Roxane Laboratories48
Completed
Not Applicable
Bioequivalency Study of Terbinafine Tablets Under Fasting ConditionsOnychomycosis
NCT00602342Roxane Laboratories30
Completed
Not Applicable
Bioequivalency Study of Terbinafine Tablets Under Fed ConditionsOnychomycosis
NCT00602251Roxane Laboratories30